{
    "code": "02022095",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022095",
    "time": "2020-02-25 12:50:34",
    "許可證字號": "衛署藥輸字第022095號",
    "註銷狀態": "已註銷",
    "註銷日期": "100\/09\/01",
    "註銷理由": "自請註銷",
    "有效日期": "102\/03\/06",
    "發證日期": "87\/03\/06",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202209500",
    "中文品名": "活路利淨持續性釋放膠囊０．２毫克",
    "英文品名": "HARNALIDGE 0.2MG CAPSULES",
    "適應症": "前列腺肥大症（增生）所伴隨的排尿障礙。",
    "劑型": "166持續性釋放膠囊",
    "包裝": "鋁箔盒裝 瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "620110R660  台灣安斯泰來製藥股份有限公司",
        "申請商地址": "台北市中山區民生東路３段１０號５樓",
        "主製造廠": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200036710",
            "成分名稱": "TAMSULOSIN HYDROCHLORIDE",
            "含量描述": "",
            "含量": "0.2000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "淡紅\/白色",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "長圓柱形",
        "標記一": "Ha0.2",
        "標記二": "山之內1,553"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "02022095.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022095&Seq=431&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "020220950009.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022095&Seq=011&Type=9"
        }
    ]
}